what is retatrutide used for weight loss: Study shows 30% body weight loss Retatrutide Subcutaneous Fat Loss Results:

More than 65 percent of participants who took the 12 mg dose reached a BMI below 30 after 80 weeks, which means they were no longer classified as having obesity

Nonetheless, considering the clinical relevance of GLP-1 therapies and their potential impact on energy balance beyond food intake and body weight, future studies should investigate whether GLP-1 agonists influence hypothalamic neuropeptide expression or signaling cascades in MC4R-deficient models

Some are curious

Na prtica, a ao busca contornar a resistncia do organismo ao GLP-1, imitando ou at amplificando a ao que ocorreria em indivduos saudveis

"Development and characterisation of a novel glucagon like peptide-1 receptor antibody"